Gal mismatch alone causes skin graft rejection in mice

Transplantation

Volumn 74, Issue 5, 2002, Pages 637-645

  Gock, Hilton ^a   Murray Segal, Lisa ^a   Salvaris, Evelyn ^a   Cowan, Peter J ^a   D'Apice, Anthony J F ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GALACTOSYLGALACTOSE; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE MODEL; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNIZATION; INCIDENCE; ISOGRAFT; KNOCKOUT MOUSE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; T LYMPHOCYTE; XENOGRAFT;

EID: 0037106493     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200209150-00009     Document Type: Article

References (39)

1. Cooper DKC, Good AH, Koren E, et al. Identification of a-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transplant Immunol 1993;1:198.
2. Platt JL, Parker W. Another step towards xenotransplantation. Nature Med 1995;1:1248.
3. Sandrin MS, Vaughan HA, McKenzie IFC. Identification of Gal (α1,3) Gal as the major epitope for pig-to-human vascularised xenografts. Transplant Rev 1994;8:134.
4. Sandrin MS, McKenzie IFC. Gal alpha(1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol Rev 1994; 141:169.
5. Galili U, Clark MR, Shohet SB, et al. Evolutionary relationship between natural anti-Gal antibody and the Gal α 1-3 Gal epitope in primates. Proc Natl Acad Sci U S A 1987;84:1369.
6. Alwayn IPJ, Basker M, Buhler L, et al. The problem of anti-pig antibodies in pig-to-primate xenografting: current and novel methods of depletion and/or suppression of production of anti-pig antibodies. Xenotransplantation 1999;6:157.
7. Cowan PJ, Aminian A, Barlow H, et al. Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. Transplantation 2000;69:2504.
8. Blakely ML, Vanderwerf WJ, Berndt MC, et al. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994;58:1059.
9. Cowan PJ, Aminian A, Barlow H, et al. Protective effects of recombinant human antithrombin III in pig-to-primate renal xenotransplantation. Am J Transplant 2002;2:520.
10. Lin SS, Weidner BC, Byrne GW, et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 1998;101:1745.
11. Boquest AC, Grupen C, Harrison SJ, et al. Production of cloned pigs from cultured fetal fibroblast cells. Biol Reprod 2002;66:1283.
12. Polejaeva IA, Chen SH, Vaught TD, et al. Cloned pigs produced by nuclear transfer from adult somatic cells. Nature 2000;407:86.
13. Lin Y, Soares MP, Sato K, et al. Long-term survival of hamster hearts in presensitized rats. J Immunol 2000;164:4883.
14. van Overdam KA, Verbakel CA, Kouwenhoven EA, et al. Negligible role for NK cells and macrophages in delayed xenograft rejection. Transpl Int 2000;13(suppl 1):S504.
15. Wang H, Rollins SA, Gao Z, et al. Complement inhibition with an anti-C5 monoclonal antibody prevents hyperacute rejection in a xenograft heart transplantation model. Transplantation 1999;68:1643.
16. Wang H, DeVries ME, Deng SP, et al. The axis of interleukin 12 and gamma interferon regulates acute vascular xenogeneic rejection. Nature Med 2000;6:549.
17. Wu G, Korsgren O, van Rooijen N, et al. The effect of macrophage depletion on delayed xenograft rejection: studies in the guinea pig-to-C6-deficient rat heart transplantation model. Xenotransplantation 1999;6:262.
18. Bach FH, Ferran C, Hechenleitner P, et al. Accommodation ofvascularized xenografts: expression of "protective genes" by donor endothelial cells in a host Th2 cytokine environment. Nature Med 1997;3:196.
19. Chong AS, Ma L, Yin D, et al. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-KO) mice. Xenotransplantation 2000;7:275.
20. Salvaris E, Gock H, Han W, et al. Naturally acquired anti-alpha Gal antibodies in a murine allograft model similar to delayed xenograft rejection. Xenotransplantation 2000;7:42.
21. Rice BH, Jr, Haynes JH, Thomas BL, et al. Analysis of skin grafting techniques in the fetal rabbit. J Invest Surg 1991;4:69.
22. Tearle RG, Tange MJ, Zannettino ZL, et al. The α-1,3 -galactosyltransferase knockout mouse: implications for xenotransplantation. Transplantation 1996;61:13.
23. Spanopoulou E, Roman CA, Corcoran LM, et al. Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. Genes Dev 1994;8:1030.
24. Xu H, Sharma A, Chen L, et al. The structure of anti-Gal immunoglobulin genes in naive and stimulated Gal knockout mice. Transplantation 2001;72:1817.
25. Gock H, Salvaris E, Murray-Segal L, et al. Hyperacute rejection of vascularized heart transplants in BALB/c Gal knockout mice. Xenotransplantation 2000;7:237.
26. Goding JW. Production of monoclonal antibodies. Monoclonal antibodies: principles and practice. London, Academic Press Limited 1996: pp 173-174.
27. Loveland BE, Henning M. Skin grafting mice. In: Green MK, Mandel TE, eds. Experimental transplantation models in small animals. Switzerland, Harwood Academic 1995: pp 195.
28. Tomonari K. A rat antibody against a structure functionally related to the mouse T-cell receptor/T3 complex. Immunogenetics 1988;28:455.
29. Ohdan H, Swenson KG, Kitamura H, et al. Tolerization of Galalpha1,3Gal-reactive B cells in pre-sensitized alpha1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism. Xenotransplantation 2001;8:227.
30. Ohdan H, Yang YG, Swenson KG, et al. T cell and B cell tolerance to GALalphal,3GAL-expressing heart xenografts is achieved in alpha1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism. Transplantation 2001;71:1532.
31. Pearse MJ, Witort E, Mottram P, et al. Anti-Gal antibody-mediated allograft rejection in alpha1,3-galactosyltransferase gene knockout mice: a model of delayed xenograft rejection. Transplantation 1998; 66:748.
32. Buhler L, Yamada K, Kitamura H, et al. Pig kidney transplantation in baboons: anti-Gal-alpha1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation. Transplantation 2001;72:1743.
33. Loss M, Vangerow B, Schmidtko J, et al. Acute vascular rejection is associated with systemic complement activation in a pig-to-primate kidney xenograft model. Xenotransplantation 2000;7:186.
34. Robson SC, Schulte am Esch J II, Bach FH. Factors in xenograft rejection. Ann N Y Acad Sci 1999;875:261.
35. Galili U, Matta KL. Inhibition of anti-Gal IgG binding to porcine endothelial cells by synthetic oligosaccharides. Transplantation 1996;62:256.
36. Minanov OP, Itescu S, Neethling FA, et al. Anti-GaL IgG antibodies in sera of newborn humans and baboons and its significance in pig xenotransplantation. Transplantation 1997;63:182.
37. Strokan V, Bennet W, Molne J, Korsgren O, Breimer M. Distribution of the Galα1-3Gal antigen in cultured adult and fetal porcine pancreatic islet cells: an immunoelectron microscopic study. Transplantation 2000;70: 846.
38. Betthauser J, Forsberg E, Augenstein M, et al. Production of cloned pigs from in vitro systems. Nat Biotechnol 2000;18:1055.
39. Onishi A, Iwamoto M, Akita T, et al. Pig cloning by microinjection of fetal fibroblast nuclei. Science 2000;289:1188.